All In Biotech

Drug Trial Radar · NCT04629833

Treatment Of Steroid-Refractory Acute Graft-versus-host Disease With Mesenchymal Stromal Cells Versus Best Available Therapy

A Randomised, Open-label, Multicentre, Phase 3 Trial of First-line Treatment With Mesenchymal Stromal Cells MC0518 Versus Best Available Therapy in Adult and Adolescent Subjects With Steroid-refractory Acute Graft-versus-host Disease After Allogeneic Haematopoietic Stem Cell Transplantation (IDUNN Trial)

Last checked: Nov 19, 2026Latest source record: Aug 13, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 210 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

210

Planned (sponsor's estimate)

Start

Aug 16, 2021

Primary completion

Aug 2027

Study completion Aug 2030

Sponsor

Lead sponsor
medac GmbHIndustry
Sponsor type
Industry
First posted
Nov 16, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary purpose of this trial is to demonstrate the superiority of MC0518 compared to the first used best available therapy (BAT) with respect to overall response rate (ORR) at Day 28 and/or overall survival (OS) until Visit Month 24 in adult and adolescent subjects with steroid-refractory acute graft-versus-host disease (SR-aGvHD).

Conditions

  • Steroid-refractory Acute Graft-versus-host Disease

Interventions

  • MC0518Biological

    MC0518 will be intravenously infused immediately after thawing.

  • BATBiological

    BAT including MMF, ECP, ATG, everolimus, and RUX will be administered based on Investigator's decision.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall Response (OR)Time frame: Day 28
  2. Overall SurvivalTime frame: Up to Month 24

Locations

42 sites in 5 countries. Site status is shown where the registry gives one.

  • Centre Hospitalier Universitaire (CHU) Amiens-Picardie - Hopital Sud

    Amiens, France · Recruiting

  • CHU Jean Minjoz

    Besançon, France · Recruiting

  • Hopital Michallon

    Grenoble, France · Recruiting

  • CHRU Lille- Hopital Claude Huriez

    Lille, France · Recruiting

  • CHU de Nantes - Hotel Dieu

    Nantes, France · Recruiting

  • CHU de Nice Hopital Archet 1

    Nice, France · Recruiting

  • Centre Hospitalier Lyon Sud Pavillon Marcel Berard 1G

    Pierre-Bénite, France · Recruiting

  • Centre Hospitalier Universitaire CHU de Toulouse

    Toulouse, France · Recruiting

  • Hopitaux De Brabois

    Vandœuvre-lès-Nancy, France · Recruiting

  • Charite Universitaetsmedizin

    Berlin, Germany · Withdrawn

  • Helios Klinikum Berlin-Buch

    Berlin, Germany · Recruiting

  • University Hospital Bonn, Medizinische Klinik III

    Bonn, Germany · Recruiting

  • Universitaetsklinikum Essen - Klinik fuer Paediatrische Haematologie und Onkologie

    Essen, Germany · Terminated

  • Klinikum der Johann Wolfgang Goethe University - University - Klinik fuer Paediatrische Haematologie und Onkologie

    Frankfurt, Germany · Recruiting

  • Universitaetsklinikum Freiburg - Zentrum fuer Kinder- und Jugendmedizin (ZKJ) - Klinik fuer Paediatrische Haematologie und Onkologie

    Freiburg im Breisgau, Germany · Terminated

  • Universitaetsklinikum Freiburg

    Freiburg im Breisgau, Germany · Recruiting

  • Universitatsklinikum

    Kiel, Germany · Recruiting

  • University Medical Center Mainz

    Mainz, Germany · Recruiting

  • Universitaetsklinikum Mannheim

    Mannheim, Germany · Recruiting

  • University Hospital Tuebingen Medical Center

    Tübingen, Germany · Recruiting

  • Klinikum rechts der Isar

    Munich, Bavaria, Germany · Recruiting

  • Universitaetsklinikum Wuerzburg - Medizinische Klinik und Poliklinik II - Zentrum fuer Allogene Blutstammzelltransplantation

    Würzburg, Bavaria, Germany · Recruiting

  • Klinikum der Johann Wolfgang Goethe-Universitaet - Frankfurt am Main

    Frankfurt am Main, Hesse, Germany · Recruiting

  • Medizinische Hochschule Hannover

    Hanover, Lower Saxony, Germany · Recruiting

  • Uniklinik Koeln

    Cologne, North Rhine-Westphalia, Germany · Active not recruiting

  • Universitaetsklinikum Essen - Klinik fuer Knochenmarktransplantation (KMT)

    Essen, North Rhine-Westphalia, Germany · Recruiting

  • Universitaetsklinikum Muenster

    Münster, North Rhine-Westphalia, Germany · Recruiting

  • Universitaetsklinikum Carl Gustav Carus Dresden

    Dresden, Saxony, Germany · Recruiting

  • Universitaetsklinikum Leipzig, Selbststaendige Abteilung fur Haematologie und Internistische Onkologie

    Leipzig, Saxony, Germany · Recruiting

  • Universitaetsklinikum Jena Klinik fuer Innere Medizin II, Haematologie und Onkologie

    Jena, Thuringia, Germany · Recruiting

  • Universitaetsklinikum Jena - Klinik fuer Paediatrische Haematologie und Onkologie

    Jena, Thuringia, Germany · Terminated

  • Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie, Paastwowy Instytut Badawczy

    Gliwice, Poland · Recruiting

  • Department of Pediatric Hematology, Oncology and BMT, Wroclaw Medical University

    Wroclaw, Lower Silesian Voivodeship, Poland · Terminated

  • Hospital Germans Trias i Pujol

    Badalona, Spain · Recruiting

  • Hospital Universitario Vall dHebron

    Barcelona, Spain · Recruiting

  • Institut Catal dOncologia

    Barcelona, Spain · Recruiting

  • Hospital Universitario Ramon y Cajal

    Madrid, Spain · Recruiting

  • Hospital Puerta De Hierro

    Madrid, Spain · Recruiting

  • Hospital Universitario Carlos Haya

    Málaga, Spain · Recruiting

  • Hospital Clinico Universitario de Valencia

    Valencia, Spain · Recruiting

Showing 40 of 42 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.